RTW Investments’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-8,035
Closed -$14.3M 33
2017
Q3
$14.3M Sell
8,035
-23
-0.3% -$32.1K 2.49% 13
2017
Q2
$11M Buy
8,058
+59
+0.7% +$71.2K 2.31% 13
2017
Q1
$9.42M Sell
7,999
-1,464
-15% -$1.49M 2.48% 13
2016
Q4
$7.56M Buy
9,463
+2,690
+40% +$2.14M 2.85% 12
2016
Q3
$5.95M Sell
6,773
-40,475
-86% -$29.3M 1.8% 15
2016
Q2
$26.5M Buy
47,248
+29,772
+170% +$16.9M 9.05% 3
2016
Q1
$9.62M Buy
17,476
+17,067
+4,173% +$10.5M 3.49% 10
2015
Q4
$340K Sell
409
-11,294
-97% -$11.3M 0.11% 29
2015
Q3
$13M Buy
11,703
+3,597
+44% +$6.56M 4.03% 9
2015
Q2
$17.7M Buy
8,106
+386
+5% +$786K 5.15% 10
2015
Q1
$12.1M Buy
+7,720
New +$10.2M 5.45% 9

Other funds holding BLUE

RTW Investments's BLUE Position: Q4 2017 in Review

RTW Investments sold out of bluebird bio (BLUE) in Q4 2017, closing a stake of 8,035 shares — an estimated $14.3M sold.

RTW Investments first reported a position in BLUE in Q1 2015 and held it in 11 quarters. The position peaked at $26.5M in Q2 2016. 296 funds tracked by Wall St. Rank hold BLUE as of Q4 2017.

  • RTW Investments reported no remaining bluebird bio position as of Q4 2017 after selling out during the quarter.
  • RTW Investments sold 8,035 bluebird bio shares in Q4 2017, an estimated $14.3M.
  • RTW Investments first reported a position in bluebird bio in Q1 2015 and held it in 11 quarters.
  • RTW Investments's bluebird bio position peaked at $26.5M in Q2 2016.
  • 296 funds tracked by Wall St. Rank held bluebird bio as of Q4 2017.

Based on RTW Investments's 13F filing for Q4 2017, filed 14 Feb 2018.